Latest Stories
ABT Q4 Deep Dive: Nutrition Weakness and Innovation Shape 2026 Outlook
Healthcare product and device company Abbott Laboratories (NYSE:ABT) missed Wall Street’s revenue expectations in Q4 CY2025 as sales rose 4.4% year on year to $11.46 billion. Its non-GAAP profit of $1.50 per share was in line with analysts’ consensus estimates.
ORI Q4 Deep Dive: Expense Pressures and Reserve Actions Offset Revenue Growth
Insurance conglomerate Old Republic International (NYSE:ORI) reported Q4 CY2025 results topping the market’s revenue expectations, with sales up 9.5% year on year to $2.36 billion. Its non-GAAP profit of $0.74 per share was 16.2% below analysts’ consensus estimates.
The 5 Most Interesting Analyst Questions From BOK Financial’s Q4 Earnings Call
BOK Financial’s fourth quarter results reflected broad-based momentum in both loan growth and fee-based income, outpacing Wall Street expectations. Management pointed to strong performances across core commercial and industrial lending, healthcare, and energy portfolios, with Texas emerging as a particularly strong market. CEO Stacy Kymes highlighted, “The growth was broad-based as our core C&I portfolio and our healthcare and energy portfolios all posted strong results this quarter.” Fee income also saw notable gains, led by record quarters in fiduciary, asset management, and transaction card services, reinforcing BOK Financial’s diversified revenue base.
5 Revealing Analyst Questions From State Street’s Q4 Earnings Call
State Street’s fourth quarter results for 2025 outpaced Wall Street’s revenue and earnings expectations, yet the market reacted negatively, with shares declining over 4%. Management attributed the quarter’s growth to robust fee income from investment services and asset management, as well as ongoing operating leverage improvements. CEO Ron O’Hanley cited the launch of new digital asset platforms and double-digit servicing fee growth in private markets as notable contributors. However, software and processing fees declined due to a shift from on-premises to cloud-based offerings, with management noting this transition is central to future recurring revenue growth.
NTRS Q4 Deep Dive: Wealth Management and AI Productivity Drive Outperformance
Financial services company Northern Trust (NASDAQ:NTRS) beat Wall Street’s revenue expectations in Q4 CY2025, with sales up 8.2% year on year to $2.13 billion. Its non-GAAP profit of $2.42 per share was 2% above analysts’ consensus estimates.
MBLY Q4 Deep Dive: Advanced Product Development and Robotics Acquisition Define Outlook
Autonomous driving technology company Mobileye (NASDAQ:MBLY) reported Q4 CY2025 results topping the market’s revenue expectations, but sales fell by 9% year on year to $446 million. On the other hand, the company’s full-year revenue guidance of $1.94 billion at the midpoint came in 2.5% below analysts’ estimates. Its non-GAAP profit of $0.06 per share was in line with analysts’ consensus estimates.
PFBC Q4 Deep Dive: Deposit Costs, Credit Quality, and Loan Growth Shape Outlook
Commercial banking company Preferred Bank (NASDAQ:PFBC) reported Q4 CY2025 results exceeding the market’s revenue expectations, with sales up 7.2% year on year to $78.07 million. Its non-GAAP profit of $2.79 per share was in line with analysts’ consensus estimates.
MKC Q4 Deep Dive: Margin Pressures Offset Modest Sales Growth as Guidance Clouds Outlook
Food flavoring company McCormick (NYSE:MKC) reported Q4 CY2025 results beating Wall Street’s revenue expectations, with sales up 2.9% year on year to $1.85 billion. Its non-GAAP profit of $0.86 per share was 1.8% below analysts’ consensus estimates.
STBA Q4 Deep Dive: Commercial Lending, Deposit Growth, and Share Buyback Highlight Quarter
Regional banking company S&T Bancorp (NASDAQ:STBA) beat Wall Street’s revenue expectations in Q4 CY2025, with sales up 11.5% year on year to $105.9 million. Its non-GAAP profit of $0.89 per share was 1.7% above analysts’ consensus estimates.
AMAL Q4 Deep Dive: Deposit Growth, Loan Expansion, and Margin Momentum Highlight Quarter
Socially responsible bank Amalgamated Financial (NASDAQ:AMAL) reported Q4 CY2025 results exceeding the market’s revenue expectations, with sales up 6.5% year on year to $87.91 million. Its non-GAAP profit of $0.99 per share was 9.4% above analysts’ consensus estimates.